These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
317 related articles for article (PubMed ID: 29121498)
1. Cardiac involvement in myotonic dystrophy: The role of troponins and N-terminal pro B-type natriuretic peptide. Valaperta R; De Siena C; Cardani R; Lombardia F; Cenko E; Rampoldi B; Fossati B; Brigonzi E; Rigolini R; Gaia P; Meola G; Costa E; Bugiardini R Atherosclerosis; 2017 Dec; 267():110-115. PubMed ID: 29121498 [TBL] [Abstract][Full Text] [Related]
2. Combined use of high-sensitivity cardiac troponin T and N-terminal pro-B type natriuretic peptide improves measurements of performance over established mortality risk factors in chronic heart failure. de Antonio M; Lupon J; Galan A; Vila J; Urrutia A; Bayes-Genis A Am Heart J; 2012 May; 163(5):821-8. PubMed ID: 22607860 [TBL] [Abstract][Full Text] [Related]
3. Cardiac troponins and N-terminal pro-brain natriuretic peptide in acute ischemic stroke do not relate to clinical prognosis. Etgen T; Baum H; Sander K; Sander D Stroke; 2005 Feb; 36(2):270-5. PubMed ID: 15604421 [TBL] [Abstract][Full Text] [Related]
4. N-Terminal Pro B-Type Natriuretic Peptide and High-Sensitivity Cardiac Troponin T Levels Are Related to the Extent of Hibernating Myocardium in Patients With Ischemic Heart Failure. Zelt JGE; Liu PP; Erthal F; deKemp RA; Wells G; O'Meara E; Garrard L; Beanlands RSB; Mielniczuk LM Can J Cardiol; 2017 Nov; 33(11):1478-1488. PubMed ID: 28966019 [TBL] [Abstract][Full Text] [Related]
5. Cardiac troponin T and NT-proBNP as diagnostic and prognostic biomarkers of primary cardiac involvement and disease severity in systemic sclerosis: A prospective study. Bosello S; De Luca G; Berardi G; Canestrari G; de Waure C; Gabrielli FA; Di Mario C; Forni F; Gremese E; Ferraccioli G Eur J Intern Med; 2019 Feb; 60():46-53. PubMed ID: 30366614 [TBL] [Abstract][Full Text] [Related]
6. Relationships of N-terminal pro-B-natriuretic peptide and cardiac troponin T to left ventricular mass and function and mortality in asymptomatic hemodialysis patients. Satyan S; Light RP; Agarwal R Am J Kidney Dis; 2007 Dec; 50(6):1009-19. PubMed ID: 18037101 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic potential of serum biomarkers for left ventricular abnormalities in chronic peritoneal dialysis patients. Wang AY; Lam CW; Wang M; Chan IH; Lui SF; Zhang Y; Sanderson JE Nephrol Dial Transplant; 2009 Jun; 24(6):1962-9. PubMed ID: 19237403 [TBL] [Abstract][Full Text] [Related]
8. Sensitive cardiac troponins and N-terminal pro-B-type natriuretic peptide in stable coronary artery disease: correlation with left ventricular function as assessed by myocardial strain. Smedsrud MK; Gravning J; Omland T; Eek C; Mørkrid L; Skulstad H; Aaberge L; Bendz B; Kjekshus J; Edvardsen T Int J Cardiovasc Imaging; 2015 Jun; 31(5):967-73. PubMed ID: 25788439 [TBL] [Abstract][Full Text] [Related]
9. Elevation of cardiac troponin T, but not cardiac troponin I, in patients with neuromuscular diseases: implications for the diagnosis of myocardial infarction. Rittoo D; Jones A; Lecky B; Neithercut D J Am Coll Cardiol; 2014 Jun; 63(22):2411-20. PubMed ID: 24747102 [TBL] [Abstract][Full Text] [Related]
10. Superior predictive value for NTproBNP compared with high sensitivity cTnT in dialysis patients: a pilot prospective observational study. Voroneanu L; Siriopol D; Nistor I; Apetrii M; Hogas S; Onofriescu M; Covic A Kidney Blood Press Res; 2014; 39(6):636-47. PubMed ID: 25571877 [TBL] [Abstract][Full Text] [Related]
11. Prognostic role of highly sensitive cardiac troponin I in patients with systolic heart failure. Tsutamoto T; Kawahara C; Nishiyama K; Yamaji M; Fujii M; Yamamoto T; Horie M Am Heart J; 2010 Jan; 159(1):63-7. PubMed ID: 20102868 [TBL] [Abstract][Full Text] [Related]
12. Sensitive troponin assays and N-terminal pro-B-type natriuretic peptide in acute coronary syndrome: prediction of significant coronary lesions and long-term prognosis. Gravning J; Smedsrud MK; Omland T; Eek C; Skulstad H; Aaberge L; Bendz B; Kjekshus J; Mørkrid L; Edvardsen T Am Heart J; 2013 May; 165(5):716-24. PubMed ID: 23622908 [TBL] [Abstract][Full Text] [Related]
13. Preprocedural N-terminal pro-B-type natriuretic peptide as a useful marker for predicting periprocedural myocardial injury following percutaneous coronary intervention in diabetic patients without cardiac dysfunction. Zeng RX; Li XL; Zhang MZ; Wang XW; Guo YL; Zhu CG; Ren Y; Li S; Zhang Y; Liu G; Xu RX; Dong Q; Li JJ Scand J Clin Lab Invest; 2015 Nov; 75(7):568-77. PubMed ID: 26203960 [TBL] [Abstract][Full Text] [Related]
14. Association between high-sensitivity cardiac troponin T and N-terminal pro-brain natriuretic peptide in a community based population. Xu R; Ye P; Luo L; Sheng L; Wu H; Xiao W; Zheng J; Wang F; Xiao T Chin Med J (Engl); 2014; 127(4):638-44. PubMed ID: 24534215 [TBL] [Abstract][Full Text] [Related]
15. Independent elevations of N-terminal pro-brain natriuretic peptide and cardiac troponins in endurance athletes after prolonged strenuous exercise. Scharhag J; Herrmann M; Urhausen A; Haschke M; Herrmann W; Kindermann W Am Heart J; 2005 Dec; 150(6):1128-34. PubMed ID: 16338248 [TBL] [Abstract][Full Text] [Related]
16. Risk stratification in stable coronary artery disease is possible at cardiac troponin levels below conventional detection and is improved by use of N-terminal pro-B-type natriuretic peptide. Lyngbæk S; Winkel P; Gøtze JP; Kastrup J; Gluud C; Kolmos HJ; Kjøller E; Jensen GB; Hansen JF; Hildebrandt P; Hilden J; Eur J Prev Cardiol; 2014 Oct; 21(10):1275-84. PubMed ID: 23723326 [TBL] [Abstract][Full Text] [Related]
17. High-sensitive troponin T and N-terminal pro-B type natriuretic peptide are associated with cardiovascular events despite the cross-sectional association with albuminuria and glomerular filtration rate. Scheven L; de Jong PE; Hillege HL; Lambers Heerspink HJ; van Pelt LJ; Kootstra JE; Bakker SJ; Gansevoort RT; Eur Heart J; 2012 Sep; 33(18):2272-81. PubMed ID: 22740385 [TBL] [Abstract][Full Text] [Related]
18. SERUM cardiac-specific biomarkers and atrial fibrillation in myotonic dystrophy type I. Russo V; Rago A; Atripaldi L; Leonardi S; Papa AA; Politano L; Golino P; Potpara TS; Nigro G J Cardiovasc Electrophysiol; 2019 Dec; 30(12):2914-2919. PubMed ID: 31579995 [TBL] [Abstract][Full Text] [Related]
19. Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Haeck JD; Verouden NJ; Kuijt WJ; Koch KT; Van Straalen JP; Fischer J; Groenink M; Bilodeau L; Tijssen JG; Krucoff MW; De Winter RJ Am J Cardiol; 2010 Apr; 105(8):1065-9. PubMed ID: 20381654 [TBL] [Abstract][Full Text] [Related]
20. Cardiac markers (BNP, NT-pro-BNP, Troponin I, Troponin T, in female amateur runners before and up until three days after a marathon. Frassl W; Kowoll R; Katz N; Speth M; Stangl A; Brechtel L; Joscht B; Boldt LH; Meier-Buttermilch R; Schlemmer M; Roecker L; Gunga HC Clin Lab; 2008; 54(3-4):81-7. PubMed ID: 18630737 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]